Clinical Trials in Nashville

Showing 9261-9280 of 17,403 trials

COMPLETEDPhase 3< 1 mile

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

NCT04029519

To evaluate the safety and efficacy of retreatment with PN40082 for lip augmentation.

Lip Augmentation

Prollenium Medical Technologies Inc.84 participantsStarted Dec 2018

Encinitas, California, United States • Miami, Florida, United States • Omaha, Nebraska, United States +3 more locations

COMPLETED< 1 mile

Long-term Effect of Lanthanum Carbonate on Bone

NCT00557323

Patients enrolled in a previous study (SPD405-309), who were exposed to lanthanum carbonate (Fosrenol), were eligible to continue on any prescribed treatment for hyperphosphatemia, including lanthanum carbonate (Fosrenol), for an additional 5 years. Patients were being observed for any bone adverse events or other serious adverse events, as well as the collection of mortality data.

Hyperphosphatemia

Shire34 participantsStarted Mar 2007

Lynwood, California, United States • Torrance, California, United States • Springfield, Massachusetts, United States +16 more locations

A Multicenter, Open-Label Retreatment Study of the Safety and Effectiveness of PN40082 for Lip Augmentation

Long-term Effect of Lanthanum Carbonate on Bone

Find Trials by Condition in Nashville

Phase I Study to Determine the Maximum Tolerable Dose of BAY94-9343 in Patients With Advanced Solid Tumors.

Product Performance of a New Silicone Hydrogel Contact Lens

Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee

Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque Psoriasis

NKTR-102 in Combination With Cetuximab in Patients With Refractory Solid Tumors (Phase 2a) and Metastatic or Locally Advanced Colorectal Cancer (Phase 2b)

Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects

Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations

StrataGraft® Skin Tissue in the Promotion of Autologous Skin Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements

A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients

Alglucosidase Alfa Pompe Safety Sub-Registry

Intercostal Nerve Block With Liposome Bupivacaine in Subjects Undergoing Posterolateral Thoracotomy

Study Assessing the Efficacy and Safety of Intravitreal Injections of DE-122 in Combination With Lucentis® Compared to Lucentis® Monotherapy in Wet Age-related Macular Degeneration Subjects

A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and Nivolumab